The latest chapter in an ongoing legal battle between Abbott Laboratories and parents of babies born prematurely is slated to ...

Jury selection in Cook County is set to kick off this week in a closely watched courtroom battle over Abbott Laboratories’ ...

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Abbott is an innovator and has made plenty of highly successful breakthroughs. That's what it did with its FreeStyle Libre ...

A Chicago trial begins Wednesday. Four families claim Abbott Laboratories' baby formula caused a dangerous bowel disease in their premature infants. The lawsuits accuse Abbott of failing to warn about ...

Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

A trial is set to begin on Wednesday in Chicago in a case brought by four families who allege that baby ​formula made by Abbott Laboratories caused their premature infants to develop a dangerous bowel ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be reporting earnings this Thursday before market open. Here’s what to look for. Abbott Laboratories met analysts’ revenue ...

If you are wondering whether Abbott Laboratories is attractively priced or just fairly valued at current levels, you are not alone. This article will help you put the current share price in context.

Abbott Laboratories Inc. defeated a proposed class action alleging it disclosed the protected health data of consumers to Meta Platforms Inc. and Google LLC in violation of state and federal privacy ...